Author:
García-Macedo Rebeca,de los Ángeles Fortis María
Publisher
Springer International Publishing
Reference313 articles.
1. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127:1–4.
2. Donath MY, Dinarello CA, Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol. 2019;19:734–46.
3. Shuwa HA, Dallatu MK, Yeldu MH, Ahmed HM, Nasir IA. Effects of adalimumab, an anti-tumour necrosis factor-alpha (TNF-alpha) antibody, on obese diabetic rats. Malay J Med Sci. 2018;25:51–62.
4. Jörns A, Arndt T, Yamada S, Ishikawa D, Yoshimoto T, Terbish T, et al. Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat. J Mol Med. 2020;98:1125–37.
5. Stenkula KG, Erlanson-Albertsson C. Am J Phys Regul Integr Comp Phys. 2018;315:R284–95.